Myelodysplastic syndromes: emerging therapies, survival, and alternative outcomes.
Scott
Bart L
BL
University of Washington Medical Center, Seattle, USA.
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001374:Azacitidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077209:Decitabine; D042241:Early Diagnosis; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D017063:Outcome Assessment, Health Care; D013534:Survival
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine